Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (DE:6NQ)
FRANKFURT:6NQ
Holding DE:6NQ?
Track your performance easily

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Financial Statements

0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Financial Overview

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s market cap is currently ―. The company's EPS TTM is €0.01; its P/E ratio is 79.27; Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenuezł 14.30Mzł 13.45Mzł 14.01Mzł 8.62Mzł 14.59M
Gross Profitzł 8.37Mzł 7.36Mzł 8.80Mzł 3.40Mzł 8.37M
EBITzł 3.78Mzł 2.55Mzł 4.03Mzł -406.00Kzł 4.07M
EBITDAzł 5.31Mzł 4.08Mzł 5.59Mzł 1.20Mzł 5.91M
Net Income Common Stockholderszł 2.57Mzł 1.54Mzł 2.73Mzł -758.00Kzł 3.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentszł 26.77Mzł 3.29Mzł 18.03Mzł 24.14Mzł 19.46M
Total Assetszł 163.10Mzł 127.33Mzł 122.78Mzł 121.72Mzł 116.83M
Total Debtzł 15.15Mzł 9.97Mzł 10.49Mzł 9.49Mzł 6.49M
Net Debtzł -11.62Mzł 6.68Mzł -7.54Mzł -14.64Mzł -12.98M
Total Liabilitieszł 57.54Mzł 49.27Mzł 46.26Mzł 47.92Mzł 42.27M
Stockholders Equityzł 105.56Mzł 78.06Mzł 76.53Mzł 73.79Mzł 74.55M
Cash Flow-
Free Cash Flowzł -12.57Mzł -13.56Mzł -7.26Mzł -422.00Kzł -8.56M
Operating Cash Flowzł 1.83Mzł 2.67Mzł -1.50Mzł -59.00Kzł -1.57M
Investing Cash Flowzł -7.16Mzł -13.70Mzł -8.18Mzł 2.07Mzł 6.23M
Financing Cash Flowzł 29.14Mzł -3.72Mzł 3.57Mzł 7.83Mzł 2.11M
Currency in PLN

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Earnings and Revenue History

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Debt to Assets

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis